| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/03/2003 | WO2003000848A2 Liver engrafting cells, assays, and uses thereof |
| 01/03/2003 | WO2003000738A2 Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate |
| 01/03/2003 | WO2003000721A2 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | WO2003000720A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 01/03/2003 | WO2003000713A1 Nucleoside compounds in hcv |
| 01/03/2003 | WO2003000709A2 Sialic acid derivatives for use as siglec inhibitors |
| 01/03/2003 | WO2003000689A1 Imidazo`1,2-a!pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
| 01/03/2003 | WO2003000684A1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000681A1 Antibacterial having quinolinecarboxamide skeleton |
| 01/03/2003 | WO2003000668A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| 01/03/2003 | WO2003000664A1 Uracil derivatives and the use thereof for treating bacterial diseases |
| 01/03/2003 | WO2003000284A1 Vaccine composition comprising a hydrotalcite-type compound |
| 01/03/2003 | WO2003000283A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 01/03/2003 | WO2003000280A2 Abin-mediated hepatitis protection |
| 01/03/2003 | WO2003000277A2 Antimicrobial peptides |
| 01/03/2003 | WO2003000273A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 01/03/2003 | WO2003000260A1 Thiazolyl amides and their use as antiviral drugs |
| 01/03/2003 | WO2003000259A1 Topical application of thiazolyl amides |
| 01/03/2003 | WO2003000244A1 Benzenesulfonyl(thio)ureas for the treatment of septic shock and sirs |
| 01/03/2003 | WO2003000243A1 Antimicrobial nanoemulsion compositions and methods |
| 01/03/2003 | WO2003000238A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 01/03/2003 | WO2003000225A2 Pharmaceutical formulation having a masked taste and method for the production thereof |
| 01/03/2003 | WO2003000200A2 β-2'-OR 3'-HALONUCLEOSIDES |
| 01/03/2003 | WO2003000185A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 01/03/2003 | WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000180A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000175A2 Pediatric formulation of gatifloxacin |
| 01/03/2003 | WO2003000024A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | WO2002083667A3 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/03/2003 | WO2002080914A3 Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments |
| 01/03/2003 | WO2002080840A3 Immunity adjuvant containing a complexed metal cation and vaccine containing same |
| 01/03/2003 | WO2002072754A9 Mva expressing modified hiv envelope, gag, and pol genes |
| 01/03/2003 | WO2002060919A9 Molecules with extended half-lives, compositions and uses thereof |
| 01/03/2003 | WO2002060869A3 Use of p38 inhibitors for the treatment of inflammation-enhanced cough |
| 01/03/2003 | WO2002060868A3 Inhibitors of prenyl-protein transferase |
| 01/03/2003 | WO2002055676A3 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 01/03/2003 | WO2002046170A8 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 01/03/2003 | WO2002045702A3 Tricyclic therapeutics for chemokine mediated diseases |
| 01/03/2003 | WO2002032918A3 Ketolide antibacterials |
| 01/03/2003 | WO2002028891A3 Listeria inocua, genome and applications |
| 01/03/2003 | WO2002026757A3 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 01/03/2003 | WO2002026209A3 Microparticles for delivery of the heterologous nucleic acids |
| 01/03/2003 | WO2002012501A3 Anti-dual integrin antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002010387A3 G-protein coupled receptors |
| 01/03/2003 | WO2002009699A3 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 01/03/2003 | WO2002008264A3 Papillomavirus infected epithelial cells and methods of producing infectious papillomavirus in epithelial cells and uses thereof |
| 01/03/2003 | WO2002008187A9 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/03/2003 | WO2002002603A3 Protein modification and maintenance molecules |
| 01/03/2003 | WO2002002131A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/03/2003 | WO2002000728A3 Methods and compositions for isolating biologically active antibodies |
| 01/03/2003 | WO2002000727A3 Gp286 nucleic acids and polypeptides |
| 01/03/2003 | WO2001098357A3 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 01/03/2003 | WO2001089502A3 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
| 01/03/2003 | CA2770453A1 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | CA2452049A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | CA2451974A1 Chimeric immunomodulatory compounds and methods of using the same |
| 01/03/2003 | CA2451864A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 01/03/2003 | CA2451745A1 .beta.-2'-or 3'-halonucleosides |
| 01/03/2003 | CA2451637A1 Liver engrafting cells, assays, and uses thereof |
| 01/03/2003 | CA2451543A1 Thiazolyl amides and their use as antiviral drugs |
| 01/03/2003 | CA2451328A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 01/03/2003 | CA2451310A1 Antimicrobial peptides |
| 01/03/2003 | CA2451250A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 01/03/2003 | CA2451026A1 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | CA2451008A1 Imidazo¬1,2-a]pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
| 01/03/2003 | CA2450969A1 Nucleic acid-associated proteins |
| 01/03/2003 | CA2450925A1 G-protein coupled receptors |
| 01/03/2003 | CA2450742A1 Pediatric formulation of gatifloxacin |
| 01/03/2003 | CA2450579A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | CA2450478A1 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 01/03/2003 | CA2450475A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | CA2450002A1 Benzenesulfonyl(thio)ureas for the treatment of septic shock and sirs |
| 01/03/2003 | CA2447249A1 Abin-mediated hepatitis protection |
| 01/03/2003 | CA2446205A1 Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate |
| 01/02/2003 | US20030004350 Pyrrolo(2,3-b)pyridine derivatives; anticancer and antiproliferative agents |
| 01/02/2003 | US20030004193 Immunomodulators; antiinflammatory agents |
| 01/02/2003 | US20030004185 Viricides, organ transplants, antiarthritic agents |
| 01/02/2003 | US20030004175 Viricides |
| 01/02/2003 | US20030004174 Antiinflammatory agents, anticancer agents, antihistamines, central nervous system disorders |
| 01/02/2003 | US20030004165 Polyazanaphthalene compounds and pharmaceutical use thereof |
| 01/02/2003 | US20030004164 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004161 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004160 Method for the preparation of oxazolidinones |
| 01/02/2003 | US20030004156 Anticholesterol agents; cardiovascular disorders; antidiabetic agents; antiproliferative agents |
| 01/02/2003 | US20030004151 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/02/2003 | US20030004144 Anticancer agents; skin disorders |
| 01/02/2003 | US20030004118 Antibiotic/benzoyl peroxide dispenser |
| 01/02/2003 | US20030004106 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 01/02/2003 | US20030003532 Novel nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 01/02/2003 | US20030003462 Novel human interleukin-like proteins and polynucleotides encoding them |
| 01/02/2003 | US20030003447 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/02/2003 | US20030003444 R9Detection of preferential polypeptide in sample; obtain sample of polypeptide, incubate with bacteriophage, monitor adjustment in activity, adjustment in activity |
| 01/02/2003 | US20030003443 Designation MVP-5180/91, deposited with the European Collection of Animal Cell Cultures under No V 920 92 318 |
| 01/02/2003 | US20030003442 Retrovirus from the HIV group and its use |
| 01/02/2003 | US20030003169 Prepared by fermenting an aqueous Glycine max (L.) extract with at least one lactic acid bacteria together with at least one yeast |
| 01/02/2003 | US20030003150 System for osmotic delivery of pharmaceutically active agents |
| 01/02/2003 | US20030003128 A prosthetic for dental implants comprising a polymeric base material(hydrogel) incorporating at least one active drug and base material releases active drug in a controlled manner when the prosthtic has been implanted in living organism |
| 01/02/2003 | US20030003112 Avipox virus containing foreign DNA from porcine reproductive and respiratory syndrome virus; immunological compositions containing the recombinant poxvirus for inducing an immunological response in a host animal |
| 01/02/2003 | US20030003107 Topical compositions containing probiotic bacillus bacteria, spores, and extracellular products and uses thereof |
| 01/02/2003 | US20030003082 Use of poly-Glu,Tyr and T cells treated therewith for neuroprotective therapy |